Articles
Aiming for balance in a conflicted world
With sustainability as a daily challenge and energy in short supply, a dependable management plan is essential
If someone asks me today, “As an executive in the biopharma industry, what are the issues that keep you awake at night?” my...
Articles
Optimizing cold chain and fill-finish capabilities for the coming wave of mRNA technologies
Reacting rapidly after the initial onset of the pandemic the biopharma industry accelerated its research into advanced anti-viral modalities including messenger RNA (mRNA) vaccines. As the pharma industry’s leaders responded to the crisis, the pandemic revealed how critical outsourcing...
Articles
Transforming the clinical data management process with Agile
Introduction
The clinical research industry wants to achieve the common goal of accelerating drug development by improving the process of data collection, data validation, analysis, and submission. Faster time to market puts pressure on every aspect of trial including Clinical...
Articles
Biopharma 2022: 5 Trends Shaping the Industry
Just 10 months ago, pharma and biotech companies rode a wave of pandemic-driven innovation and historic funding levels into what many hoped would be another banner year. Now, after several quarters of shifting expectations, we can take stock: what...
Articles
How to plan cGMP-compliant clinical batches
For companies developing new injectable medications, manufacturing issues have become one of the greatest and most consistent early stumbling blocks. In fact, the FDA has issued more than 600 manufacturing citations in just the last five years.
In the earliest...
Articles
The future of high-throughput screening
High-throughput screening (HTS) is a method for drug discovery that allows automated testing of large numbers of chemical and biological compounds for a specific biological target. Mass spectrometry is particularly appealing for HTS as it avoids a number of...
Articles
Converting Injectable Therapies to Combination Drug-Device Products
How to seize market opportunities while navigating the requirements of both drug therapies and delivery devices
The global biopharma market has recently experienced a remarkable period of evolution and expansion. In that time, parenteral medications have become one of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.